Literature DB >> 34532562

Monitoring Natural Killer Cell Function in Human Ovarian Cancer Cells of Ascitic Fluid.

Vikash Kumar1, Asok Mukhopadhyay2.   

Abstract

Natural killer (NK) cells are the major effectors of the innate immune system when activated resulting in modulation of immune response of the host defense through target cell lysis and secretion of cytokines. Precise functions of NK cells are essential for the treatment outcome of different virus infections and malignant diseases. NK cells impart cytotoxic effect to the target cells lacking MHC class I molecules and thus the final readout of the activity is death of target cells. The NK cell function is evaluated by the 51Cr-release and/or flow cytometry-based assays. In the present protocol, we have determined the activation of NK cells by the liberation of IL-10 and IFNγ, and subsequently its function by enumerating the number of dead tumor cells originally isolated from the ascitic fluid of ovarian cancer patients. The entire assay is based on cells of the healthy donors and patients. Besides determining function, this method is able to demarcate between NK-cell sensitive and insensitive tumor cells. This technique enables researchers to study NK cell functions in healthy donors or in patients to reveal their impact on different malignancies and to further discover new therapeutic strategies.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Ascitic fluid; Cell death; Flow-cytometry; MHC class I antigen; NK cells activation; PBMCs; ovarian cancer cells

Year:  2018        PMID: 34532562      PMCID: PMC8342124          DOI: 10.21769/BioProtoc.3124

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  13 in total

1.  CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity.

Authors:  R Lichtenfels; W E Biddison; H Schulz; A B Vogt; R Martin
Journal:  J Immunol Methods       Date:  1994-06-24       Impact factor: 2.303

2.  Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity.

Authors:  G Konjević; V Jurisić; I Spuzić
Journal:  J Immunol Methods       Date:  1997-01-15       Impact factor: 2.303

Review 3.  Recognition of tumors by the innate immune system and natural killer cells.

Authors:  Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

4.  Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH.

Authors:  Tamar S Rubin; Kejian Zhang; Carrie Gifford; Adam Lane; Sharon Choo; Jack J Bleesing; Rebecca A Marsh
Journal:  Blood       Date:  2017-03-07       Impact factor: 22.113

Review 5.  Use of allogeneic NK cells for cancer immunotherapy.

Authors:  Melissa A Geller; Jeffrey S Miller
Journal:  Immunotherapy       Date:  2011-12       Impact factor: 4.196

6.  Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype.

Authors:  Md Zahid Akhter; Surender K Sharawat; Vikash Kumar; Veena Kochat; Zaffar Equbal; Mallika Ramakrishnan; Umesh Kumar; Sandeep Mathur; Lalit Kumar; Asok Mukhopadhyay
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

Review 7.  Natural killer cells in human cancer: from biological functions to clinical applications.

Authors:  Estrella Mariel Levy; María Paula Roberti; José Mordoh
Journal:  J Biomed Biotechnol       Date:  2011-04-26

Review 8.  The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy.

Authors:  Sourav Paul; Girdhari Lal
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

9.  A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry.

Authors:  Srinivas S Somanchi; Kelsey J McCulley; Anitha Somanchi; Leo L Chan; Dean A Lee
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

10.  Measuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay.

Authors:  Mobin A Karimi; Eric Lee; Michael H Bachmann; Ana Maria Salicioni; Edward M Behrens; Taku Kambayashi; Cynthia L Baldwin
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.